Oral bisphosphonates and colorectal cancer.

Vogtmann, Emily; Corley, Douglas A; Almers, Lucy M; Cardwell, Chris R; Murray, Liam J; Abnet, Christian C

Vogtmann, Emily; Corley, Douglas A; Almers, Lucy M; Cardwell, Chris R; Murray, Liam J; Abnet, Christian C.

Affiliation

Vogtmann E; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Corley DA; Kaiser Permanente, San Francisco Medical Center, San Francisco, California, USA.
Almers LM; Kaiser Permanente, San Francisco Medical Center, San Francisco, California, USA.
Cardwell CR; Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Murray LJ; Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Abnet CC; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Sci Rep ; 7: 44177, 2017 03 10.

Article in En | MEDLINE | ID: mdl-28281559

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Databases, Factual / Diphosphonates Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Sci Rep Year: 2017 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google